Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst Marion Roussel Licenses Database from Genome Therapeutics

Premium

WALTHAM, Mass.--Genome Therapeutics here has licensed its proprietary microbial sequence database, PathoGenome, to Hoechst Marion Roussel. The pharmaceutical company will use the database to develop antiinfective products. Hoechst will pay annual subscription fees and royalties for nonexclusive access to the database. PathoGenome contains genomic sequence information from 24 microbial organisms assembled through Genome Therapeutics' pathogen genomics research and public-domain sources, as well as in-depth sequence analysis and proprietary bioinformatics tools.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.